The evolution of hematopoietic cells under cancer therapy
The mutational effects of chemotherapies on healthy cells are unclear. Here, the authors show that the mutational signature of platinum-based drugs -but not 5-fluorouracil- is detectable in secondary acute myeloid leukemia, implying that the clonal expansion begins after the start of therapy.
Guardado en:
Autores principales: | Oriol Pich, Albert Cortes-Bullich, Ferran Muiños, Marta Pratcorona, Abel Gonzalez-Perez, Nuria Lopez-Bigas |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/957ed69350be465bbc94c7e7d45fe2b7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Oncodrive-CIS: a method to reveal likely driver genes based on the impact of their copy number changes on expression.
por: David Tamborero, et al.
Publicado: (2013) -
Improvement of hematopoietic stem cell transplantation in the targeted therapy era
por: ZHANG Xi, et al.
Publicado: (2021) -
Environmental variation and the evolution of large brains in birds
por: Ferran Sayol, et al.
Publicado: (2016) -
Glutamine metabolism regulates endothelial to hematopoietic transition and hematopoietic lineage specification
por: Leal Oburoglu, et al.
Publicado: (2021) -
3D models of the hematopoietic stem cell niche under steady-state and active conditions
por: Lisa Rödling, et al.
Publicado: (2017)